Klaus‐Peter Janssen

47.1k total citations · 2 hit papers
123 papers, 6.6k citations indexed

About

Klaus‐Peter Janssen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Klaus‐Peter Janssen has authored 123 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 47 papers in Oncology and 22 papers in Immunology. Recurrent topics in Klaus‐Peter Janssen's work include Genetic factors in colorectal cancer (20 papers), Colorectal Cancer Treatments and Studies (17 papers) and Cellular Mechanics and Interactions (14 papers). Klaus‐Peter Janssen is often cited by papers focused on Genetic factors in colorectal cancer (20 papers), Colorectal Cancer Treatments and Studies (17 papers) and Cellular Mechanics and Interactions (14 papers). Klaus‐Peter Janssen collaborates with scholars based in Germany, United States and France. Klaus‐Peter Janssen's co-authors include Sylvie Robine, Daniel Louvard, Fatima El Marjou, Ulrich Nitsche, Robert Rosenberg, Matthias Maak, Benny Hung‐Junn Chang, Mei Li, Pierre Chambon and Lawrence Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Klaus‐Peter Janssen

116 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium

2004 780 citations Klaus‐Peter Janssen, Daniel Louvard et al. profile →
Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature

2023 79 citations Sebastian Jarosch, Andreas Wanisch et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Klaus‐Peter Janssen Germany	42	3.5k	2.1k	995	840	780	123	6.6k
Gerhard Fritz Germany	45	3.9k 1.1×	1.8k 0.8×	735 0.7×	1.3k 1.5×	521 0.7×	136	6.7k
Yi Liu China	45	5.2k 1.5×	1.3k 0.6×	1.5k 1.5×	1.1k 1.3×	472 0.6×	247	8.4k
Jau‐Song Yu Taiwan	50	4.3k 1.2×	1.4k 0.7×	728 0.7×	1.3k 1.6×	553 0.7×	232	7.3k
Wayne A. Phillips Australia	43	4.1k 1.2×	2.3k 1.1×	1.0k 1.0×	1.3k 1.5×	1.1k 1.3×	169	7.2k
Joseph Locker United States	50	3.6k 1.0×	3.0k 1.4×	619 0.6×	654 0.8×	1.2k 1.5×	176	8.4k
Onno Kranenburg Netherlands	52	5.4k 1.6×	3.0k 1.4×	807 0.8×	1.5k 1.8×	907 1.2×	188	9.8k
Ulrike Stein Germany	50	4.1k 1.2×	2.4k 1.1×	700 0.7×	1.3k 1.5×	832 1.1×	222	7.6k
Kwan Man Hong Kong	53	3.2k 0.9×	1.5k 0.7×	1.2k 1.2×	1.6k 1.9×	1.4k 1.9×	176	7.7k
Chuan‐Yuan Li United States	40	3.6k 1.0×	1.6k 0.8×	1.3k 1.3×	1.4k 1.7×	351 0.5×	115	6.0k
James C.H. Hardwick Netherlands	41	2.7k 0.8×	2.1k 1.0×	450 0.5×	898 1.1×	1.1k 1.4×	125	5.9k

Countries citing papers authored by Klaus‐Peter Janssen

Since Specialization

Citations

This map shows the geographic impact of Klaus‐Peter Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus‐Peter Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus‐Peter Janssen more than expected).

Fields of papers citing papers by Klaus‐Peter Janssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus‐Peter Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus‐Peter Janssen. The network helps show where Klaus‐Peter Janssen may publish in the future.

Co-authorship network of co-authors of Klaus‐Peter Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus‐Peter Janssen. A scholar is included among the top collaborators of Klaus‐Peter Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus‐Peter Janssen. Klaus‐Peter Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larralde, Martin, Widya Johannes, Klaus‐Peter Janssen, et al.. (2025). Heterologous Expression of a Cryptic BGC from Bilophila sp. Provides Access to a Novel Family of Antibacterial Thiazoles. ACS Synthetic Biology. 14(3). 967–978. 1 indexed citations

Chen, Wei, Raquel Mejías‐Luque, Klaus‐Peter Janssen, et al.. (2025). Universal, untargeted detection of bacteria in tissues using metabolomics workflows. Nature Communications. 16(1). 165–165. 2 indexed citations

Johannes, Widya, Laura M. Carroll, Tianzhe Liu, et al.. (2024). Bacillamide D produced by Bacillus cereus from the mouse intestinal bacterial collection (miBC) is a potent cytotoxin in vitro. Communications Biology. 7(1). 655–655. 2 indexed citations

Wortmann, Esther, Marijana Basic, André Bleich, et al.. (2024). Gut microbiota prevents small intestinal tumor formation due to bile acids in gnotobiotic mice. PubMed. 3(4). 44–44.

Hüser, Norbert, et al.. (2024). Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failure. Signal Transduction and Targeted Therapy. 9(1). 168–168.

Prokopchuk, Olga, Marc E. Martignoni, Klaus‐Peter Janssen, et al.. (2023). Specific miRNAs are associated with human cancer cachexia in an organ‐specific manner. Journal of Cachexia Sarcopenia and Muscle. 14(3). 1381–1394. 9 indexed citations

Jarosch, Sebastian, Andreas Wanisch, Klaus‐Peter Janssen, et al.. (2023). Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Gut. 72(7). 1258–1270. 79 indexed citations breakdown →

Dietl, Andreas, Klaus‐Peter Janssen, Moritz Middelhoff, et al.. (2023). Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Zeitschrift für Gastroenterologie. 61(8). e404–e405. 6 indexed citations

Schult, David, Sandra Reitmeier, Tobias Lahmer, et al.. (2022). Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes. 14(1). 2031840–2031840. 59 indexed citations

10.

Maurer, H. Carlo, David Schult, Sandra Reitmeier, et al.. (2022). Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. Journal of Fungi. 8(12). 1265–1265.

11.

Metwaly, Amira, Sandra Reitmeier, Theresa Baumeister, et al.. (2022). Analysis of Fecal, Salivary, and Tissue Microbiome in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma. SHILAP Revista de lepidopterología. 1(5). 755–766. 1 indexed citations

12.

Jarosch, Sebastian, Katja Steiger, Klaus‐Peter Janssen, et al.. (2021). Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometry. Cell Reports Methods. 1(7). 100104–100104. 18 indexed citations

13.

Bien, Tanja, Markus Perl, Ulrich Nitsche, et al.. (2020). MALDI-2 Mass Spectrometry and Immunohistochemistry Imaging of Gb3Cer, Gb4Cer, and Further Glycosphingolipids in Human Colorectal Cancer Tissue. Analytical Chemistry. 92(10). 7096–7105. 36 indexed citations

14.

Janssen, Klaus‐Peter. (2016). Predicting disease recurrence in stage II colon cancer: expression signatures and other biomarkers. Translational Cancer Research. 5(6). 1 indexed citations

15.

Geyer, Philipp, Matthias Maak, Ulrich Nitsche, et al.. (2016). Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit. Molecular Cancer Therapeutics. 15(5). 1008–1017. 45 indexed citations

16.

Berger, Emanuel, Eva Rath, Detian Yuan, et al.. (2016). Mitochondrial function controls intestinal epithelial stemness and proliferation. Nature Communications. 7(1). 13171–13171. 149 indexed citations

17.

Goossens-Beumer, Inès J., Remco Derr, Henk P.J. Buermans, et al.. (2014). MicroRNA Classifier and Nomogram for Metastasis Prediction in Colon Cancer. Cancer Epidemiology Biomarkers & Prevention. 24(1). 187–197. 26 indexed citations

18.

Vignjevic, Danijela Matic, Marie Schoumacher, Nancy Gavert, et al.. (2007). Fascin, a Novel Target of β-Catenin-TCF Signaling, Is Expressed at the Invasive Front of Human Colon Cancer. Cancer Research. 67(14). 6844–6853. 237 indexed citations

19.

Abal, Miguel, Antònia Obrador‐Hevia, Klaus‐Peter Janssen, et al.. (2007). APC Inactivation Associates With Abnormal Mitosis Completion and Concomitant BUB1B/MAD2L1 Up-Regulation. Gastroenterology. 132(7). 2448–2458. 30 indexed citations

20.

Weber, Georg F., Florian Gaertner, Wolfgang Erl, et al.. (2006). IL-22-Mediated Tumor Growth Reduction Correlates with Inhibition of ERK1/2 and AKT Phosphorylation and Induction of Cell Cycle Arrest in the G2-M Phase. The Journal of Immunology. 177(11). 8266–8272. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact